Brad, I am a Slater and Gordon shareholder. For quite a while now actually, my holding has not changed in recent days.
I like to vent a bit because it really was far worse than I had anticipated. I bought this with a contrarian outlook. Big debt a cashflow lesson here.
As you have seen in my posts generally I post a pretty measured opinon on the business going forward. With all the cost cuts there is hope but, the only other option after that is a proportionate dilution relative to the shortfall of the PIP.
You have turned into a bit of a krispy of late I might add
I hope we pull through this I will still be here, I don;t need the money and I will see this through as a lesson.
- Forums
- ASX - By Stock
- SGH
- MN discn PPR and is SGH undervalued ?
MN discn PPR and is SGH undervalued ?, page-50
-
-
- There are more pages in this discussion • 213 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online